[Other] Comparative Cardiovascular, Lipid, and Safety Effects of Lipid-Modifying Therapies in Diabetes: An Agent-, Class-, and Dose-Level Network Meta-Analysis |
|
This post will be closed automatically in 2026-09-07 07:30
Reward10points
|
40
Evaluating the Effectiveness of the Charlson Comorbidity Index in Predicting Immune Checkpoint Inhibitor-Related Adverse Events
50
No Association Between BMI and Immunotoxicity or Clinical Outcomes for Immune Checkpoint Inhibitors
20
The Study of Corrosion Behaviour of Cu In Some Commercial Beverages By Chemical and Electrochemical Measurement
20
Effect of physical exercise on inactivated COVID-19 vaccine antibody response in the elderly
50
Formation and evolution of second phase particles in 1060 aluminum alloy sheet produced by twin-roll casting and annealing
